key: cord-0709611-4q55k2f1
authors: Ray, Mary Katherine; McMichael, Alana; Rivera-Santana, Maria; Noel, Jacob; Hershey, Tamara
title: Technological Ecological Momentary Assessment Tools to Study Type 1 Diabetes in Youth: Viewpoint of Methodologies
date: 2021-06-03
journal: JMIR Diabetes
DOI: 10.2196/27027
sha: 7a901916d9ba6f513d5f0883ec5f45cbe2159208
doc_id: 709611
cord_uid: 4q55k2f1

Type 1 diabetes (T1D) is one of the most common chronic childhood diseases, and its prevalence is rapidly increasing. The management of glucose in T1D is challenging, as youth must consider a myriad of factors when making diabetes care decisions. This task often leads to significant hyperglycemia, hypoglycemia, and glucose variability throughout the day, which have been associated with short- and long-term medical complications. At present, most of what is known about each of these complications and the health behaviors that may lead to them have been uncovered in the clinical setting or in laboratory-based research. However, the tools often used in these settings are limited in their ability to capture the dynamic behaviors, feelings, and physiological changes associated with T1D that fluctuate from moment to moment throughout the day. A better understanding of T1D in daily life could potentially aid in the development of interventions to improve diabetes care and mitigate the negative medical consequences associated with it. Therefore, there is a need to measure repeated, real-time, and real-world features of this disease in youth. This approach is known as ecological momentary assessment (EMA), and it has considerable advantages to in-lab research. Thus, this viewpoint aims to describe EMA tools that have been used to collect data in the daily lives of youth with T1D and discuss studies that explored the nuances of T1D in daily life using these methods. This viewpoint focuses on the following EMA methods: continuous glucose monitoring, actigraphy, ambulatory blood pressure monitoring, personal digital assistants, smartphones, and phone-based systems. The viewpoint also discusses the benefits of using EMA methods to collect important data that might not otherwise be collected in the laboratory and the limitations of each tool, future directions of the field, and possible clinical implications for their use.

Type 1 diabetes (T1D) is one of the most common chronic childhood diseases with a rapidly rising incidence and prevalence [1, 2] . It is an autoimmune disease characterized by the loss of insulin-producing β cells of the pancreas, leading to an inability to use glucose as fuel, thus requiring life-saving exogenous insulin administration [3] . The management of glucose is challenging because patients must consider a myriad of factors when making diabetes care decisions (eg, insulin administration and glucose checks), such as the amount of carbohydrates consumed, insulin administered, physical activity, stress, illness, hormonal changes that cause natural spikes in glucose (eg, dawn phenomenon), and access to diabetes treatment technologies (eg, continuous glucose monitoring [CGM] and insulin pump) [4] [5] [6] . This complex web of factors and subsequent management decisions can lead to a significant amount of glucose variability throughout the day, with frequent fluctuations between normal (euglycemia), high (hyperglycemia), and low (hypoglycemia) glucose levels [4] . In fact, research has shown that young children with T1D are in a hyperglycemic state approximately 50% of the time [7] and experience thousands of hypoglycemic events in their lifetime [8] . These types of glycemic states have been shown to be associated with short-and long-term complications, including, but not limited to, hypoglycemia (sometimes severe), diabetic ketoacidosis (DKA), heart disease, retinopathy, nephropathy, neuropathy, sleep disturbances, and cognitive impairments [9] [10] [11] .

At present, most of what is known about each of these complications and the health behaviors that may lead to them have been uncovered in the clinical setting or laboratory-based research using medical record data extraction, retrospective interviews asking participants to recall information from past events, and tests that measure health over extended periods (eg, hemoglobin A 1c [HbA 1c ]). However, there are known limitations with measurements of this type, given their inability to capture the dynamic behaviors, feelings, and physiological changes associated with T1D that fluctuate from moment to moment throughout the day. Importantly, these measurements can also be confounded by recall bias [12] , thus limiting our capacity to characterize and understand T1D. A better understanding of T1D in daily life could potentially aid in the development of behavioral and pharmaceutical interventions to improve diabetes care and mitigate the negative medical complications often associated with T1D. Therefore, there is a need to measure repeated, real-time, real-world features of T1D in daily life. This approach, known as ecological momentary assessment (EMA), can include a variety of methods, such as handheld computers, diaries, phones, smartphones, activity trackers, and physiological monitors (eg, CGM and ambulatory blood pressure monitoring [ABPM]) [12] . These methods can provide more valid ecological representations of patients' experiences, behaviors, and physiological measures with in-the-moment collection of information [12] . Fortunately, the widespread use of EMA is becoming more feasible because of the lower cost, greater familiarity, and usefulness of ambulatory technological devices such as smartphones and activity trackers (eg, Fitbit), especially in youth [13] [14] [15] . As a result, the use of wearable devices to collect real-world data is becoming increasingly popular across a variety of scientific fields to better understand disease states in a person's natural environment [16] .

The use of EMA to understand factors related to T1D in daily life may be particularly important in youth, as they typically have more challenges with glycemic control than other age groups with diabetes [17] and are reaching developmental milestones that could impact their daily glucose management behaviors. For example, youth may behave differently with their T1D care if they are in a group of peers they feel the need to fit in with, or act differently, as they begin to seek independence from their parents [18] . Furthermore, it has been suggested that youth may not have yet developed the full cognitive abilities needed to integrate the information and skills needed to make appropriate management decisions [19] . This limitation could be even more concerning in patients with T1D, as a rich body of the literature has shown that acute complications (eg, severe hypoglycemia and DKA) and chronic hyperglycemia measured in the laboratory are associated with lower cognitive scores [11] . Furthermore, youth may still be unburdened by medical complications that often accompany T1D later in life. EMAs could potentially provide a more sensitive tool for early tracking of T1D complications that may not yet be detected in a clinical setting. Taken together, EMA methods could provide insight into important daily factors that influence T1D care behaviors and track physiological changes that may be predictive of complications in this particularly vulnerable population.

This viewpoint aims to describe EMA tools that have been used to collect data in the daily lives of youth with T1D and discuss studies that explored the nuances of T1D in daily life. This viewpoint focuses on several methods used to assess behavioral and physiological measures, including CGM, actigraphy, ABPM, personal digital assistants (PDAs), smartphones, and phone-based systems. The viewpoint also includes a discussion of the benefits of using EMA methods to collect important data that might not otherwise be collected in the laboratory and the limitations of each tool, future directions of the field, and possible clinical implications of using these tools.

The following keywords were searched using the PubMed database between January and September 2020: ("type 1 diabetes" and "ecological momentary assessment"), ("type 1 diabetes" and "EMA"), ("type 1 diabetes" and "actigraphy"), ("type 1 diabetes" and "field study"), ("type 1 diabetes" and "smartphone app"), ("type 1 diabetes" and "smartphone"), ("type 1 diabetes" and "phone"), ("type 1 diabetes" and "personal digital assistant"), ("type 1 diabetes" and "PDA"), ("type 1 diabetes" and "mHealth"), ("type 1 diabetes" and "mobile health"), ("type 1 diabetes" and "wearable"), ("type 1 diabetes" and "electronic health"), ("type 1 diabetes" and "eHealth"), ("type 1 diabetes" and "sleep"), ("type 1 diabetes" and "ambulatory"), ("type 1 diabetes" and "accelerometer"), ("type 1 diabetes" and "CGM"). Each pair of search terms was combined with "youth," "adolescent," and "children." Articles were reviewed starting in 2005, given the rapid development of technology, particularly real-time CGM, around this year.

To narrow the focus of the viewpoint, articles for the literature review portion of each section were not typically included in our synthesis of the literature if youth with T1D were not the primary study population (eg, articles combining all youth and adult data and articles focused on the caregivers of youth with T1D); the article was a review, case report, book chapter, editorial, conference abstract, study protocol, or comment; the article was written in a language other than English; the study was conducted in an animal model; the article did not directly seek to obtain EMA measures multiple times per day on a technological device; the study was conducted entirely in an in-lab setting; physical activity was the primary focus of an actigraphy study; or the article focused on flash glucose monitoring versus CGM. This viewpoint was intended to provide an overview of popular EMA tools to collect data in youth with

It is becoming increasingly clear that HbA 1c has many limitations and is not the only important factor for measuring glycemic control and predicting the risk of medical complications in T1D [20] . Although glucose variability remains poorly understood, it has recently been highlighted as a potential risk factor for developing disease complications [21] . Understanding the importance of glucose variability is becoming much more feasible with the use of CGM technology, perhaps the most well-known EMA method used in T1D. Real-time CGMs typically measure interstitial glucose every 1-5 minutes via a sensor embedded under the skin, and information is then transmitted to a tracking device such as a smartphone app, receiver, or insulin pump [22] [23] [24] . Most current CGMs usually measure glucose every 5 minutes, with 288 measurements per day [24] compared with self-monitored blood glucose (SMBG), which is often only measured to test for hypoglycemia or in situations such as with meals, exercise, bedtime, or certain tasks (eg, driving). This can vary among participants but typically requires SMBG measurements 6-10 times per day [25] . Thus, the frequent testing of glucose with CGM provides a more comprehensive view of glucose patterns and variability over time compared with glucose snapshots provided by SMBG or HbA 1c . Data collected via CGM can provide information on glucose trends, the amount of time a person is in a specified glucose range (eg, euglycemia: 70-180 mg/dL), asymptomatic glycemic events, the amount of glycemic variability, the mean glucose over discrete periods (eg, 14 days), overnight glucose patterns-not typically captured with SMBG-and postprandial glucose peaks [22, [25] [26] [27] [28] [29] .

This more encompassing view of glucose patterns can aid health care providers in the development of optimized goals and plans aimed at improving glucose levels and mitigating negative medical complications [20] . CGM has also been shown to be empowering for youth with T1D, as it allows them to easily access data such that they can have more control over their glucose, provides motivation for dietary intake changes, and helps them manage hyper-and hypoglycemia [30] . As a result of these benefits, the use of CGM is increasing rapidly, especially in young children [31] [32] [33] 

Data collected with CGM have also provided an important tool for testing the feasibility and effectiveness of insulin delivery systems, insulin treatments, adjunctive diabetes medications, T1D screening, new glucose monitoring systems, algorithms for the promotion of improved glycemic control, sensor-augmented therapy algorithms, and closed-loop systems ; diabetes alert dogs [92] ; education programs aimed at improving impaired hypoglycemia unawareness, daily therapy decisions, and cardiovascular health [93] [94] [95] ; and use of glucose sharing data with others [96] . This technology has also been used to assess the relationship between continuous glucose measures and other diabetes-related outcomes, including long-term glycemic control, dysglycemia [97, 98] , future T1D diagnosis or dysglycemia in preclinical youth [99] [100] [101] , HbA 1c [102] [103] [104] [105] , C-peptide [102] , insulin sensitivity [106] , severe hypoglycemia [107] , time in target range [108] [109] [110] , glucose variability [109] [110] [111] [112] [113] , detection of hypo-or hyperglycemia [108] [109] [110] [114] [115] [116] , glycated albumin [104] , fructosamine [104] , and 1,5-anhydroglucitrol [104] . Furthermore, CGM has been used to determine the relationship between continuous glucose measures and other medical outcomes, including body composition [117] , markers of inflammation [118] , cardiovascular health [119] , and brain health (eg, white matter integrity) [120] .

Thus far, there is substantial evidence to suggest that CGM use is associated with improved glycemic control, including lower or improved HbA 1c , reaching target HbA 1c , decreased hyper-or hypoglycemic events or time in a hyper-or hypoglycemic state [137, 138, [145] [146] [147] [148] , reduced SD or mean glucose [134, 146] , reduced glucose variability [134, 137, 148] , and increased time in the target glucose range [127, 137, 146] . CGM use has also been shown to be related to improved treatment and outcomes, including more advanced and optimized treatment recommendations by physicians to improve glycemic outcomes [149, 150] , increased satisfaction with diabetes treatment [123, 151] , improved perceived awareness of or hormonal responses to hypoglycemia [123, 152] , reduced fear of hypoglycemia [153, 154] , reduced patient distress [139] , and altered amount of insulin used per day (eg, both decreased and increased insulin use per day) [140, 154] . Outside of direct diabetes outcomes, CGM use has been shown to be associated with a higher quality of life (when a new algorithm was used to help guide insulin administration) [155] , improved school attendance [151] , and increased comfort with diabetes management in the school setting [156] .

Furthermore, studies have shown significant benefits of using CGM sensor-augmented pump therapy systems that can initiate automatic functions for suspending insulin in the event of current or predicted low-glucose and closed-loop systems. For example, predictive low-glucose suspension or hyperglycemia and hypoglycemia minimization functions have been shown to be related to improvements in HbA 1c [89] 85, 86] . Furthermore, youth have expressed positive experiences with closed-loop systems, including self-reported positive impact on sleep, their routines, and safety [157] . Interestingly, a study evaluated the ability of a heart rate monitor to inform closed-loop system decisions with exercise and found that the incorporation of heart rate data into the closed-loop system improved time below a glucose level of 70 mg/dL even though it did not reduce the number of hypoglycemic events [48] . When comparing the 2 types of systems, studies have shown significant benefits for closed-loop systems versus sensor-augmented therapies with glucose suspend functions. Although there is a significant amount of evidence showing the benefits of CGM in improving T1D, it is important to note that not all studies have found statistically significant improvements in all measures between CGM users and CGM nonusers or with the initiation of CGM use across different time points and age groups [126, 129, 138, 140, 148, 153, 154, [158] [159] [160] [161] [162] [163] [164] [165] [166] . The lack of evidence for the benefits of CGM could potentially be the result of the amount of time spent using the tool. For example, more and consistent use versus intermittent use, full compliance with the research protocol, age, baseline glycemic control, and self-efficacy with CGM use have all been suggested to be important factors for clinical improvements with CGM [56, 122, 124, 131, 132, 134, 140, 148, 159, 161, [167] [168] [169] .

It is clear that CGM has many advantages; however, there are limitations to its use. There is still the potential for measurement error, false alarms (eg, alert for hypoglycemia when the patient is euglycemic), alarms that do not awake patients at night [24, [170] [171] [172] [173] , signaling loss-driven gaps in data, and data interpretation challenges [174] . The sensors can also be uncomfortable or painful or fall out, which is of significant concern given the high cost of the technology and difficulties with insurance coverage [24, 171, [173] [174] [175] [176] [177] [178] [179] . There can also be an annoyance or alarm fatigue with frequent alerts about glucose and sensor status, potentially causing patients to feel overwhelmed or embarrassed, especially in public environments [28, 171, 172, 177, [180] [181] [182] . Furthermore, the abundance of information provided by CGMs may cause anxiety, frustration, and self-thoughts of failure or that they have bad blood glucose patterns, especially if they have difficulty interpreting the substantial amount of data provided by CGM [24, 28, 174] . In the same vein, youth may fear chastisement from others (eg, parents and physicians) if they have frequent hypo-or hyperglycemic events that would not otherwise be observed with SMBG [24] . All these factors could significantly affect the adherence to CGM use. However, programs are being developed to help better teach youth how to overcome the challenges associated with CGM [183] .

Overall, frequent, repeated glucose measurements with CGM can provide great benefits over one-time snapshots of glucose. In addition to a significant enrichment of glucose information, CGMs could further enhance our knowledge of T1D when paired with other EMA methods to determine how in-the-moment behaviors are associated with subsequent glucose patterns and how glucose patterns relate to daily health (eg, sleep). CGM is growing in popularity among youth with T1D and has significant advantages over in-lab glucose measures or SMBG, as it provides a wealth of knowledge that can be used to better understand glucose fluctuations. However, there are still limitations to its use, such as inaccurate readings and discomfort, that need to be addressed in future technological development.

Actigraphy is a noninvasive, motion-sensing tool often worn on the wrist for extended periods to collect information about measures such as physical activity or sleep [184] . Sleep is of particular concern for youth with T1D, as research has shown consistent sleep disturbances compared with their peers without T1D [10] , with an average of approximately 26 minutes less sleep per night [185] . Actigraphy provides numerous advantages over in-lab methods of collecting sleep data, as it is inexpensive and can be used to examine sleep patterns over multiple days [186] [187] [188] . Furthermore, it is relatively suitable for correctly identifying sleep periods in youth and can assess numerous facets of sleep (eg, sleep onset, sleep onset latency, frequency of nocturnal waking, duration of nocturnal waking, wake after onset, the midpoint of sleep, nap duration, total sleep period, wake time, total sleep time, sleep efficiency, fragmentation of sleep, and longest continuous sleep episodes) by repeatedly measuring movement and heart rate (with some, but not all trackers) [188] . Taken together, actigraphy offers an affordable and convenient method of measuring sleep at home, providing a unique means of collecting more information about how sleep is affected in the daily lives of youth with T1D.

Actigraphy has uncovered important relationships between sleep and diabetes care behaviors in daily life. For example, both average sleep duration and sleep variability have been shown to be associated with diabetes care behaviors (eg, less average sleep duration related to decreased SMBG or more sleep variability related to decreased SMBG) [189, 190] . Furthermore, actigraphy-derived data have shown a relationship between HbA 1c and altered sleep (eg, more total sleep time related to lower HbA 1c ) [51, 189] , found a relationship between sleep in children and sleep in their parents [191] , and showed that youth with T1D who have obesity may have different sleep patterns compared with patients with T1D without obesity [192] .

Importantly, actigraphy has uncovered relationships between specific patterns of glucose control (eg, greater glucose variability, more time in hypoglycemia, and suboptimal HbA 1c ) and disrupted or variable sleep [53, [193] [194] [195] . For example, Monzon et al [193] found that measures of sleep (eg, sleep onset latency and nighttime awakenings) predicted more variability in glucose on weekend days, highlighting the potential importance of maintaining consistent sleep routines throughout the week.

It is important to note that most of these studies were correlational and therefore could not determine the directionality of the relationship between sleep and glycemic control [51, 53, 189, 190, 195] . It has been suggested that there is bidirectionality in the relationship (eg, more glycemia outside of the recommended range increases the likelihood of hypoglycemia and hyperglycemia at night, which can then impair sleep [190] ). Monzon et al [193] found a bidirectional association between glucose variability and awakenings on weekend nights, suggesting that youth with more weekend awakenings may have more glycemic variability in the following days and that youth may have more awakenings after weekend days where they have more glucose variability. They also suggest that future research considers how both physiology (eg, physiological changes in glucose) and behavior (eg, waking to check glucose at night) could explain the bidirectional relationship between glucose control and sleep [193] .

Given that youth with T1D often have sleep impairments or do not meet current sleep recommendations [51, 189, 190, [193] [194] [195] [196] , interventional strategies are needed to help improve sleep in this population; 2 recent studies found that smartphone app-based interventions improved sleep measured via actigraphy in youth with T1D. Jaser et al [197] found that their intervention improved sleep efficiency and increased total sleep time by approximately 48 minutes. Similarly, Perfect et al [198] found that their sleep intervention protocol increased actigraphy-measured sleep by approximately 29 minutes. These studies highlight the promise of mobile health (mHealth) interventions (ie, medical care supported by a mobile device) [199] to treat sleep in this vulnerable population. Furthermore, not only is actigraphy being used to assess whether these mHealth interventions can improve sleep, but it is also being used to determine whether new diabetes management systems (eg, hybrid closed-loop systems) can improve sleep among youth with T1D and their parents [200] .

It is important to note that although actigraphy has been shown to be relatively sensitive in measuring sleep, not all studies have shown comparative results between actigraphy and the gold standard of sleep measurement-polysomnography-and it has been shown that actigraphy has low specificity for certain measures such as detection of wake after sleep onset [188] . It has been suggested that actigraphy may be a better tool for collecting typical sleep data and may be less reliable in adequately measuring disturbed sleep [186] . Furthermore, studies have used a wide range of tracking devices (eg, Fitbits and Actigraphs), which could potentially create discrepancies between results [188] . More tool development and validation testing are needed to measure sleep adequately, especially disrupted sleep.

Actigraphy is increasingly being used to assess sleep in youth with T1D. The EMA tool provides an inexpensive way to objectively measure sleep in the daily lives of youth in their natural environments. Studies have shown more sleep disturbances in youth with T1D, and these disturbances have also been shown to be related to important T1D self-care behaviors and glycemic control. Promising preliminary studies have shown the potential use of app-based interventions to improve sleep; however, more trials are needed. Furthermore, more validation testing and consistent tracker use should be considered in future studies.

Cardiovascular disease is a significant concern in patients with T1D. Unfortunately, in-office blood pressure measurements only capture a snapshot of blood pressure, which changes continuously throughout the day [201] . In-office monitoring is also influenced by masked hypertension (patients can have normal in-office blood pressure but elevated when measured 24 hours per day out of the office) and the white-coat phenomenon (patients have elevated blood pressure when measured in the office but have normal blood pressure in daily life) [202] . Specific to youth with T1D, 9.5% have been shown to have masked high blood pressure, whereas 32% have been shown to have white-coat hypertension [203] . To mitigate these phenomena and better assess the impact of circadian rhythms on blood pressure, researchers and clinicians have turned to ABPM as a tool to collect EMA data on heart function [202, 204, 205] . Importantly, a more accurate determination of heart function using the EMA tool could lead to a more appropriate use of blood pressure medications [206] . ABPM is typically measured via an ambulatory blood pressure cuff every 15-20 minutes during the day and every 20-30 minutes at night (varying by study), providing a large amount of information on blood pressure and heart rate variability in varying contexts [201] .

A large number of studies have used ABPM to measure cardiovascular function outcomes in youth with T1D and found that patients often have high blood pressure measures (eg, high systolic or diastolic pressure at different times of day), prehypertension, or higher blood pressure than their peers who do not have T1D [203, [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] , with higher blood pressure-measured with ABPM being predictive of future hypertension [220] . Many factors have been found to be associated with measures of high blood pressure in this population, including higher HbA 1c [208, 209, 215, 226] , age [209] , sex [208, 209] , diabetes duration [208, 209, 214, 225, 226] , unstable glycemic control [225] , insulin dose [209, 215, 225] , BMI [209, 215, 226] , genetics [227, 228] , triglycerides [214] , high salt intake [226] , and selectins involved in inflammation (eg, E-selectin) [214, 229] .

People without T1D typically have a dip in nocturnal systolic and diastolic blood pressure by approximately 10%-20% from daytime blood pressure [201] . However, research using ABPM has consistently shown that patients with T1D often do not have this normal dip or have less dipping than youth without T1D [207, 209, 218, 221, 222, 224, [230] [231] [232] [233] [234] . This abnormal dipping has been shown to be related to age, sex (ie, being female associated with more abnormal dipping) [209] , HbA 1c [209, 226] , higher ambulatory arterial stiffness-a potential marker of arterial stiffness to predict heart mortality [232] , reduced 24-hour heart rate [233, 234] , reduced mean daytime heart rate [233, 234] , prolonged QT interval (interval from the Q to the T electrical wave), greater left ventricular end-diastolic and end-systolic diameters [233, 234] , greater left ventricular mass index [234] , and specific heart oscillation patterns [235] . In addition, not only does high blood pressure present a problem in itself, but it is also associated with other negative medical complications. In fact, several studies have found a relationship between high blood pressure measures obtained with ABPM and markers of kidney damage or disease in youth with T1D [211, 215, 220, 222, [236] [237] [238] [239] .

Although there is substantial evidence for increased blood pressure in youth with T1D, not all studies have found robust, statistically significant relationships between diabetes and high blood pressure across contexts [240, 241] . For example, Raes et al [240] found no significant difference in blood pressure between youth with T1D and those without T1D when participants were at rest but observed significantly higher blood pressure in patients with T1D while they were participating in exercise. Furthermore, not all studies have found a relationship between blood pressure and markers of kidney damage [218, 242] . For example, Soltysiak et al [242] found no relationship between blood pressure and increases in neutrophil gelatinase-associated lipocalin, an early marker of kidney damage.

ABPM use in research is limited by the potential interference it presents with a patient's activities in daily life and inaccurate readings if the cuff is placed incorrectly during measurement [243] . Therefore, more research is needed to develop less intrusive and more valid devices or protocols. Furthermore, the nocturnal dipping status may not be consistently reproducible. Thus, it has been suggested that the focus of research is on 24-hour systolic blood pressure versus dipping status [206] .

ABPM provides an excellent tool for measuring real-world heart function while avoiding potentially confounding variables, such as the white-coat phenomenon and masked hypertension, which might otherwise conceal heart function complications when measured in a laboratory setting. The use of this EMA method has uncovered important heart function complications in youth with T1D. Overall, blood pressure measurements obtained from ABPM have consistently been shown to be elevated in youth with T1D, and this increased blood pressure has been associated with markers of kidney damage. Thus, real-world testing could highlight the need to conduct earlier tracking of heart function and interventions in youth with T1D.

All of the EMA tools discussed so far have passively collected repeated, real-time data such that the patients did not consciously and purposefully have to interact with the device. To collect more information about a patient's conscious behavior or perceived experiences, more active EMA methods are needed, such as PDAs. PDAs are often referred to as handheld computers, as they can connect to the internet, be used to organize information, and communicate via email or a personal computer [244] . Although PDAs can function similarly to more recent technological developments (eg, smartphones), supplying PDAs to participants could help reduce limitations related to patients not having their own devices or owning devices that are not compatible with the study software.

Several studies have been conducted using PDAs to determine how environmental factors impact patient experiences and diabetes care behaviors in youth with T1D in real-world settings. For example, Helgeson et al [18] had patients complete periodic measures of interpersonal interactions (eg, had the participant had a social interaction? Was the interaction positive or negative?) and mood on a PDA throughout the day and found that less enjoyment and being upset from a social interaction predicted depressed mood and anxiety. PDA devices also found that patients were more likely to check their glucose when they reported a strong desire to blend in with their companions and less likely to check glucose when they wanted to impress people [245] . Taken together, the results suggest that peer relationships in daily life are associated with self-care behavior and psychological well-being in youth with T1D.

As described in the General Introduction, lower cognitive scores have been shown to be associated with severe hypoglycemic events, DKA, and chronic hyperglycemia when measured in a laboratory setting [11] ; thus, it is important to understand how momentary cognitive function is related to T1D in daily life. Gonder-Fredrick et al [246] had patients use a PDA device to determine the relationship between SMBG and cognitive function (ie, mental math and reaction time task) in a real-world setting. Performance was worse during periods of hypoglycemia (<54 mg/dL) and hyperglycemia (>400 mg/dL) compared with euglycemia (although not statistically different for hyperglycemia and the reaction time task). Thus, mental efficiency is altered by hypo-and hyperglycemia in the daily lives of youths with T1D [246] . Importantly, it is possible that cognitive impairment is not only affected by glucose levels but may also affect subsequent glucose levels through poor T1D care decisions. More research is needed to better understand the complex relationship between glucose levels, cognitive impairment, and T1D care decisions.

PDA devices have also provided important information on T1D outcomes in daily life. Gonder-Fredrick et al [247] assessed real-world glucose symptoms in which youths were asked to estimate their current blood sugar and rate symptoms on a PDA (with the help of a parent) immediately before measuring SMBG. The youths struggled to correctly estimate glucose, making clinically accurate estimates less than one-third of the time and did not detect >40% of hypoglycemic episodes. Children less accurate in detecting low glucose levels also had more severe low blood sugar levels in the subsequent 6-month period. This inability to recognize hypoglycemia is problematic and suggests that more education may be needed to improve the detection of low glucose levels in this population [247] .

As with most EMA methods that require self-report, there can be uncertainty about the validity of the data, given that they are collected without researcher or clinician supervision [248] . Therefore, it is possible that someone other than the participant is completing the measure or that the patient is not fully dedicated to the task at hand. With the technological nature of PDAs, there is always the risk of software and hardware issues [12] (eg, poor connection to the system transmitting the data). Furthermore, as with most EMA studies, there is a significant concern with testing compliance [12] and dropping out when asked to use these devices in everyday life. Finally, PDAs may now be less available as they have been replaced with smartphones.

PDAs have captured complex relationships and nuances that could significantly impact a patient's daily life, which might otherwise be lost if measured only in a clinical or laboratory setting. Several psychosocial and contextual factors have been found to be associated with T1D self-care behavior and psychological well-being, such as wanting to fit in and wanting to impress others. Research has also revealed information about T1D symptoms in the real world, including undetected hypoglycemia and impaired cognitive function. Information collected via PDAs could potentially help provide an avenue for directly addressing these factors to improve T1D management and treatment.

The use of phones to collect EMA data is becoming more feasible as their ownership in childhood and adolescence continues to increase. In those aged 8-12 years, phone ownership increased from 24% to 41% between 2015 and 2019, and in those aged 13-18 years, ownership increased from 67% to 84% [14] . Phone ownership has been shown to be even more common in youth with T1D, with a study reporting that over 92% of patients aged ≥12 years (n=279) carry a phone in their daily lives [249] . The increased feasibility provides an ideal window for the development of new assessment platforms using these tools. As with PDAs, phones can collect data in a variety of ways. For example, they can prompt participants with a notification to enter information at fixed or random intervals throughout the day, or patients could be instructed to upload diabetes information when applicable (eg, when they miss an insulin dose, they tell an app what was happening in their lives at the moment that led to the missed dose).

Researchers have developed several smartphone apps to collect EMAs in pursuit of assessing environmental factors related to T1D care behaviors. For example, the MyDay smartphone app developed by Mulvaney et al [250] was used to identify psychosocial and contextual factors that impact self-care behaviors (eg, SMBG and insulin administration) in youth with T1D and found that patients reported significant social and contextual barriers to T1D management, including being with family, friends, and alone, fatigue, hunger, having fun, and being in a rush. Importantly, some of the barriers were shown to be significantly associated with self-care behaviors (eg, fatigue was associated with more missed insulin administration) [250] , highlighting the potential for tailored treatments to address specific environmental barriers.

Several apps and systems have also been developed that synchronize cellphones to glucometers, allowing patients to upload glucose readings to their phones (eg, SMBG and CGM readings) or synchronize their glucose to their parents' phones. These apps and systems have also been designed to include features that allow a patient to manually log blood glucose, carbohydrate intake, meals, exercise, medications, insulin pump basal and bolus settings, glucose trends, illness, or life events (eg, vacation), often providing users with an integrated view of the myriad of daily factors that could affect glycemic control. Several of the apps include chat rooms for youth with T1D to communicate with one another, functions that allow patients to contact health care providers, reminders for patients to participate in T1D self-care behaviors, insulin and carbohydrate calculators, tips for diabetes treatment, information about T1D, and gamification incentives for participating in diabetes self-care behaviors [19, [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] .

For example, the DiaMob app was partly developed to help patients understand carbohydrate counting and insulin dosing.

Participants were asked to provide information about physical activity around mealtimes and the amount of insulin needed to account for carbohydrate intake and capture a photograph of their food. Glucose data could also be integrated to provide an all-inclusive app interface with information about glucose levels, activity, insulin dosage, and meal composition. The results revealed that patients consumed more carbohydrates than they expected and, in the beginning, miscalculated the insulin dosage required to account for carbohydrate intake. Patients found the app supportive for diabetes management, feeling that observing their food made them more mindful of their eating habits and helped them calculate carbohydrates more accurately [19] . A previous study using the app found that participants thought the pictures, physical activity information, integration of pre-and postprandial glucose measurements, and insulin dosages helped them develop a better understanding of how those factors impact glucose measurements [251] .

Text message-and phone call-based systems have also been used to collect EMA [252, [267] [268] [269] . For example, Warnick et al [269] recently tested the accuracy of self-reported SMBG and identified in-the-moment factors that create barriers and motivation for SMBG checks via text surveys. They found that only 39.6% of self-reported SMBG values were accurate, with health being a motivator for SMBG checks, whereas forgetting, not having their devices, and ignoring diabetes tasks were reported as barriers [269] . Furthermore, phone call-based systems have been developed to determine what real-life dietary factors (eg, carbohydrate intake, fiber intake, and physical activity) impact glucose fluctuations and diabetes self-care behaviors (eg, SMBG checks and insulin administration) [270, 271] . For example, Mulvaney et al [271] used an automated, interactive touch-tone telephone response system to determine the environmental factors influencing SMBG checks and insulin administration. Overall, participants reported missing more glucose checks in the morning (59.4%) than in the afternoon (27.5%) or evening (13.2%). Participants also reported missing more insulin doses in the morning (74.1%) than in the afternoon (17.9%) or evening (8.0%) [271] , suggesting that mornings may be particularly challenging for youth with T1D. This information, which may otherwise have been missed if collected in a laboratory setting, could potentially provide a unique target for more tailored interventions addressing challenges with morning routines.

The apps and phone-based programs often include educational components (eg, teaching T1D-related information, promoting problem-solving skills, reminders to participate in diabetes care behaviors, positive psychology interventions, and cognitive behavioral treatments) with the goal of improving T1D self-care and glycemic control [272] [273] [274] [275] [276] [277] [278] [279] [280] [281] [282] [283] [284] . These app and phone-based mHealth programs have been shown to be related to improved glycemic control (eg, lower HbA 1c , mean blood glucose, mean fasting glucose, and postprandial glucose levels), increased frequency of SMBG testing, reduced frequency of hypoglycemia, improved quality of life, decreased disengagement coping, reduced parental intrusions in diabetes care for youth who checked glucose regularly, reduced urgent diabetes-related calls by school nurses, decreased hospitalizations, reduced emergency department visits, increased feelings of safety, increased confidence, decreased worry over hypoglycemia, and increased T1D self-care compliance [13, 254, 255, 257, 258, 262, 263, 272, 273, [276] [277] [278] 280, 285, 286] . For example, the SuperEgo system was designed to provide patients with individually tailored texts on topics such as stigma, burnout, stress, and sports and exercise with regard to T1D. They found that the intervention group maintained their HbA 1c level, whereas the control group had an increased HbA 1c level [272] . These tools can also be integrative such that participants receive momentary feedback about their T1D treatment based on the information they log in the app or phone system. For example, Bin-Abbas et al [276] found that youth in an intervention where patients sent glucose readings to their T1D management team and received feedback (eg, how to adjust insulin dosage to avoid dysglycemia) had improved T1D control.

Importantly, these studies have revealed that certain patient characteristics may make a child with T1D more likely to respond to phone-based systems. For example, Herbert et al [268] found that girls and patients who said they sent a large amount of personal texts in their daily lives were more likely to respond to a text message-based intervention. Furthermore, Bergner et al [275] found that youths with T1D found a text-based system for a positive psychology intervention more acceptable than phone call-based systems. However, although some studies have found that app-and phone-based program usage can improve T1D not all found statistically significant differences [282, 287] , and some found increased patient burden. For example, studies have shown increased conflict in families with app usage, including an increased perception of conflict about logging blood sugars, a sense of increased nagging from parents if the youths checked their glucose irregularly, decreased caring behaviors from parents, and increased unsupportive behaviors from parents [263, 281] .

Social app platforms have also been considered for better understanding and treating T1D in youths in their daily lives. For example, a study found that participants wanted to incorporate a social platform in a diabetes decision tool app [288] , whereas another study used the Instagram social platform as a tool to collect data about what T1D looks like in daily life [289] . However, it is important to note that youth with T1D could also potentially feel pressured or discouraged by social media if they observe others posting about perfect blood glucose levels if they do not obtain similar readings. This is concerning as research has shown a relationship between comparison in social media and poor mental health [290] . Furthermore, there can be misleading information on social media about diabetes and health [291] , which could potentially be harmful to self-care in youth.

The limitations associated with smartphone apps and phone-based systems are similar to those described for PDA. However, there are additional limitations. If a study uses a bring-your-own-device protocol, there may still be a sizable number of participants who do not own a device, resulting in selection bias if only individuals in higher economic groups have access to their own device. A bring-your-own-device platform might also require the development of different smartphone app versions (eg, iOS and Android) as participants may have a variety of phone types (eg, iPhone vs Android) that may not be compatible with the same app version. Finally, there may be concerns about damage to a participant's own device or a study-provided device, such as cracked screens, that may interfere with data collection. On the other hand, if the study needs to provide a device for all participants, there could be study cost challenges.

Overall, smartphone apps and phone-based systems can provide a platform for collecting information that helps paint a more detailed picture of the daily experiences and challenges youth with T1D face that may not be otherwise captured reliably if assessed retrospectively in a laboratory or clinical setting. Thus far, numerous psychosocial and contextual factors have been found to be associated with T1D self-care behavior, such as fatigue, time of day, inaccessible devices, forgetfulness, and ignoring diabetes tasks. Taken together, this knowledge could potentially promote more defined interventional targets for improved glycemic control in youth with T1D (eg, developing different morning routines to promote self-care) that could potentially be delivered via an mHealth platform.

Overall, EMA has been used to better understand T1D in the daily lives of youth. EMA collection methods can provide significant advantages over in-lab testing, which may be confounded by phenomena such as recall bias and changes in behavior that result from the mere fact of being observed (eg, white-coat phenomenon) [12, 202] . These methods also have the benefit of producing a much richer data set to better describe patterns of physiological and behavioral responses in T1D versus one-time snapshots.

EMA tools have already provided important information on care behaviors, physiological fluctuations, and complications of T1D that youth can experience in everyday life. CGMs have provided a great deal of information on glucose patterns, actigraphy has highlighted daily sleep challenges, and ABPM has shown the prominence of abnormalities in blood pressure and heart function in young people with T1D that can lead to other complications such as kidney disease. PDAs, smartphone apps, and phone-based systems have also uncovered numerous psychosocial and contextual environmental factors associated with T1D self-care (eg, wanting to fit into a group or time of day) and the negative consequences of glucose outside the recommended range (eg, cognitive impairment) [18, 246, 250] . Preliminary studies have also shown that smartphone apps and phone-based systems provide a potential platform for mHealth interventions for T1D and other conditions, such as impaired sleep [197, 198] .

Given the significant benefits of EMA, there is a great need for its expansion to study T1D-related factors in the daily lives of youth. Larger and more diverse study samples are of the utmost importance. Including individuals with newly diagnosed T1D could provide the opportunity for clinicians to intervene with behaviors that can lead to medical complications early before they are established versus trying to eliminate them later in the course of the disease. EMA methods may also provide an opportunity to reach populations currently underrepresented in research, such as those with lower socioeconomic status, racial or ethnic minority status, or those living in rural areas that may have less access to clinics and research facilities [292, 293] . This is especially important because some of these populations have consistently been shown to have worse T1D-related outcomes [294] . Furthermore, EMA methods are less dependent on physical laboratory space, which may be an advantage in circumstances when there are barriers to access, such as during the COVID-19 pandemic or for patients who have barriers to travel to the laboratory.

Future research should also expand the use of combined EMA method systems. An area in which this combination could be particularly helpful is measuring the relationship between glucose patterns and T1D complications in daily life, such as cognitive impairment (eg, glucose measured via CGM or cognitive function measured via testing on a smartphone app). Given that acute T1D complications and chronic hyperglycemia have been associated with acute and long-lasting cognitive differences when measured in the laboratory [11] and the relationship between SMBG and cognitive impairment in Gonder-Fredrick's EMA study [246] , it is essential to better understand the relationship between daily glucose patterns measured via CGM and cognitive function in the real world, especially considering that youths spend about 25% of their time participating in school activities during the academic year [295, 296] , which requires substantial, ongoing cognitive effort using cognitive functions that can fluctuate throughout the day [297] [298] [299] [300] [301] .

There may also be other fluctuating short-term complications associated with daily glycemic changes to be explored, such as vision. In-lab research has shown that short-term fluctuations in glucose can significantly alter nerve function and morphology in the eye [302] . Given that youths can have significant glucose variability [7] , it is possible that they may experience daily vision changes. Research studies using EMA methods could be conducted to determine how frequently patients experience vision changes throughout the day and whether regular disruptions predict long-term complications such as retinopathy.

Furthermore, psychiatric conditions are more common in individuals with T1D than in those without T1D [303] . EMA methods can be used to gain better insight into the patterns of psychiatric symptoms in daily life. For example, one could collect repeated information about anxiety to determine whether its origin is T1D related, given that symptoms of glucose variability and feelings of anxiety can overlap (eg, shakiness and sweatiness because of hypoglycemia or because of nerves over a school exam). The timing of symptoms could also be evaluated to determine if there is a relationship between these symptoms and glucose fluctuations (eg, anxiety is higher with frequent swings in glucose). This information could potentially be used to aid therapists and medical care teams in tailoring behavioral interventions to help ameliorate symptoms when they are most severe.

More sophisticated analytical systems could also be used to better integrate data from different EMA modalities (eg, machine learning) for a more fully developed model of factors that predict T1D self-care behaviors or disease complications. The rapid development of new T1D care systems, such as the closed-loop system, makes this a unique time to conduct such combination EMA studies. EMA data collection could also be combined with mHealth interventional platforms to make treatment adjustments in real time, as youths appear to enjoy technology platforms. Furthermore, these technology-based interventions may provide motivation, self-efficacy, and adherence benefits [304] . The implementation of mHealth interventions while simultaneously collecting in-the-moment data could potentially help individualize treatment by providing a type of precision-based medicine.

In conclusion, as shown in the textboxes (Textboxes 1 and 2) , EMA methods such as CGM, actigraphy, ABPM, PDAs, smartphone apps, and phone-based systems have unique strengths that can help the field better understand T1D in the daily lives of youth. Such an understanding could potentially lead to tailored interventions to improve quality of life and reduce the risk of short-and long-term complications of T1D. However, the field is still in its infancy and should be expanded in future research to address the limitations of each tool. Textbox 1. Strengths of popular technological ecological momentary assessment tools to measure type 1 diabetes in the daily lives of youth, including continuous glucose monitoring, actigraphy, ambulatory blood pressure monitoring, personal digital assistants, and phone app, call, and text-based systems.

Continuous glucose monitoring 

Primary Care of Child With Chronic Condition 4th Edition

SEARCH for Diabetes in Youth Study. Incidence trends of type 1 and type 2 diabetes among youths

Genetics, pathogenesis and clinical interventions in type 1 diabetes

Good to know: factors affecting blood glucose

The dawn phenomenon revisited: implications for diabetes therapy

Intersecting health policy and the social determinants of health in pediatric type 1 diabetes management and care

Persistently high glucose levels in young children with type 1 diabetes

Hypoglycemia in type 1 diabetes mellitus

Type 1 diabetes

Sleep in type 1 diabetes: implications for glycemic control and diabetes management

Cognition and type 1 diabetes in children and adolescents

Ecological momentary assessment

A mobile app for the self-management of type 1 diabetes among adolescents: a randomized controlled trial

The common sense census: media use by tweens and teens

Systematic review of the validity and reliability of consumer-wearable activity trackers

Advancing neuroscience through wearable devices

HbA1c levels in type 1 diabetes from early childhood to older adults: a deeper dive into the influence of technology and socioeconomic status on HbA1c in the T1D exchange clinic registry findings

Peer relationships and diabetes: retrospective and ecological momentary assessment approaches

Integrating visual dietary documentation in mobile-phone-based self-management application for adolescents with type 1 diabetes

Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range

Glycaemic variability in diabetes: clinical and therapeutic implications

Continuous glucose monitoring sensors for diabetes management: a review of technologies and applications

Assessment and monitoring of glycemic control in children and adolescents with diabetes

Continuous glucose monitoring versus self-monitoring of blood glucose in children with type 1 diabetes-are there pros and cons for both?

Diabetes technology: standards of medical care in diabetes-2019

Let the Algorithm Do the Work": reduction of hypoglycemia using sensor-augmented pump therapy with predictive insulin suspension (SmartGuard) in pediatric type 1 diabetes patients

In Home Closed Loop Study Group. In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes

Outpatient closed-loop control with unannounced moderate exercise in adolescents using zone model predictive control

Performance of an artificial pancreas system for young children with type 1 diabetes

Real-world use of do-it-yourself artificial pancreas systems in children and adolescents with type 1 diabetes: online survey and analysis of self-reported clinical outcomes

Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring-derived glycemic makers in children and adolescents with type 1 diabetes

How does a predictive low glucose suspend (PLGS) system tackle pediatric lifespan challenges in diabetes treatment? Real world data analysis

Prospective analysis of the impact of commercialized hybrid closed-loop system on glycemic control, glycemic variability, and patient-related outcomes in children and adults: a focus on superiority over predictive low-glucose suspend technology

Use of continuous glucose monitoring trends to facilitate exercise in children with type 1 diabetes

Diabetes Alert Dogs (DADs): an assessment of accuracy and implications

Effect of education on impaired hypoglycemia awareness and glycemic variability in children and adolescents with type 1 diabetes mellitus

Practical approach to using trend arrows on real-time continuous glucose monitoring system in type 1 diabetes adolescents living camp setting treated with multiple daily injection or continuous subcutaneous insulin infusion insulin therapy

Impact of real-time continuous glucose monitoring use on glucose variability and endothelial function in adolescents with type 1 diabetes: new technology-new possibility to decrease cardiovascular risk?

Real-time sharing and following of continuous glucose monitoring data in youth

Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c

Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: determination of optimal sampling duration

Continuous glucose monitoring and HbA1c in the evaluation of glucose metabolism in children at high risk for type 1 diabetes mellitus

Early hyperglycemia detected by continuous glucose monitoring in children at risk for type 1 diabetes

Continuous glucose monitoring predicts progression to diabetes in autoantibody positive children

Diabetes Research in Children Network (DirecNet)Type 1 Diabetes TrialNet Study Groups. CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes

The interrelationship of HbA1c and real-time continuous glucose monitoring in children with type 1 diabetes

Diabetes Research in Children Network (DirecNet) Study Group. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial

The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes

Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset

Type 1 diabetes outcomes of children born in Israel of Eritrean asylum seekers

Use of continuous glucose monitoring in young children with type 1 diabetes: implications for behavioral research

Diabetes Research in Children Network (DirecNet) Study Group. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function

High day-to-day glucose variability: a frequent phenomenon in children and adolescents with type 1 diabetes attending summer camp

A comparison of average daily risk range scores for young children with type 1 diabetes mellitus using continuous glucose monitoring and self-monitoring data

Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes

The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo-and hyperglycemia in children under 7 years of age

Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes

Detection and treatment efficacy of hypoglycemic events in the everyday life of children younger than 7 yr

Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes

Glycemic variability predicts inflammation in adolescents with type 1 diabetes

Motivational Interview to improve vascular health in Adolescents with poorly controlled type 1 Diabetes (MIAD): a randomized controlled trial

Alterations in white matter structure in young children with type 1 diabetes

T1D ExchangeDPV Registries. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: international comparison from the T1D Exchange and DPV Initiative

Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial

Improvement in psychosocial outcomes in children with type 1 diabetes and their parents following subsidy for continuous glucose monitoring

Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance

Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring

Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes

Continuous glucose monitoring in children with type 1 diabetes

Diabetes Research in Children Network (DirecNet) Study Group. FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group

Continuous glucose monitoring and intensive treatment of type 1 diabetes

T1D Exchange Clinic Network. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry

Continuous Glucose Monitoring (CGM) adherence in youth with type 1 diabetes: associations with biomedical and psychosocial variables

Baseline psychosocial characteristics predict frequency of continuous glucose monitoring in youth with type 1 diabetes

Diabetes device use and glycemic control among youth with type 1 diabetes: a single-center, cross-sectional study

Continuous glucose monitoring use and glucose variability in pre-school children with type 1 diabetes

Early initiation of diabetes devices relates to improved glycemic control in children with recent-onset type 1 diabetes mellitus

Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes

Time in range in children with type 1 diabetes using treatment strategies based on nonautomated insulin delivery systems in the real world

Short-term use of continuous glucose monitoring system adds to glycemic control in young type 1 diabetes mellitus patients in the long run: a clinical trial

Continuous glucose monitoring associated with less diabetes-specific emotional distress and lower A1c among adolescents with type 1 diabetes

Clinical efficacy of professional continuous glucose monitoring in improving glycemic control among children with type 1 diabetes mellitus: an open-label randomized control trial

Overweight and obese children with optimal control in the T1D Exchange Registry: how are they different from lean children with optimal control?

CGM Intervention in TeensYoung Adults with T1D (CITY) Study Group, CDE10. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial

Effectiveness of continuous glucose monitoring in children, adolescents, and young adults with poorly controlled type 1 diabetes

Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

Use of factory-calibrated real-time continuous glucose monitoring improves time in target and HbA in a multiethnic cohort of adolescents and young adults with type 1 diabetes: the MILLENNIALS study

Is there an optimal strategy for real-time continuous glucose monitoring in pediatrics? A 12-month French multi-center, prospective, controlled randomized trial (Start-In!)

Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care

Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: the pediatric DIACCOR study

Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes

Continuous glucose monitoring in children with type 1 diabetes improves well-being, alleviates worry and fear of hypoglycemia

Sydney Diabetes centre's experience of the Australian Government's roll out of subsidised continuous glucose monitoring for children with type 1 diabetes mellitus

An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life

Real-time continuous glucose monitoring systems in the classroom/school environment

Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy

Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study

Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial

Diabetes Research in Children Network (DirecNet) Study Group. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years

German Working Group for insulin pump treatment in pediatric patients, German BMBF Competence Network Diabetes. Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria

Diabetes Research in Children Network Study Group. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes

Sustained continuous glucose monitor use in low-income youth with type 1 diabetes following insurance coverage supports expansion of continuous glucose monitor coverage for all

Has subsidized continuous glucose monitoring improved outcomes in pediatric diabetes?

Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis

Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes

Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties

Continuous blood glucose monitoring in diabetes treatment

Real-life utilization of real-time continuous glucose monitoring: the complete picture

Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes

Response to nocturnal alarms using a real-time glucose sensor

Benefits and barriers of continuous glucose monitoring in young children with type 1 diabetes

Continuous glucose monitoring in children and adolescents

High frequencies of dermatological complications in children using insulin pumps or sensors

Cost, hassle, and on-body experience: barriers to diabetes device use in adolescents and potential intervention targets

Cutaneous reactions to continuous glucose monitoring and continuous subcutaneous insulin infusion devices in type 1 diabetes mellitus

Diabetes Research in Children (DirecNet) Study Group. Skin and adhesive issues with continuous glucose monitors: a sticky situation

Continuous glucose monitoring in youth with type 1 diabetes

Monitoring of pediatric type 1 diabetes

Executive functions and adherence to continuous glucose monitoring in children and adolescents with type 1 diabetes

Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience

Encyclopedia of the Neurological Sciences

Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis

Practical aspects of actigraphy and approaches in clinical and research domains

Wrist actigraphy

Use of actigraphy for assessment in pediatric sleep research

Diabetes management mediates the association between sleep duration and glycemic control in youth with type 1 diabetes mellitus

Sleep habits in adolescents with type 1 diabetes: variability in sleep duration linked with glycemic control

Sleep in parental caregivers and children with type 1 diabetes

Differences in sleep architecture according to body mass index in children with type 1 diabetes

Associations between objective sleep behaviors and blood glucose variability in young children with type 1 diabetes

Daily variations in sleep and glucose in adolescents with type 1 diabetes

Sleep and glycemia in youth with type 1 diabetes

Brief report: sleep disturbances in young children with type 1 diabetes

Sleep coach intervention for teens with type 1 diabetes: randomized pilot study

The development of a clinically relevant sleep modification protocol for youth with type 1 diabetes

mHealth: new horizons for health through mobile technologies

Impact of the hybrid closed-loop system on sleep and quality of life in youth with type 1 diabetes and their parents

Ambulatory blood pressure monitoring in pediatrics

Ambulatory blood pressure monitoring in the diagnosis and management of hypertension

Arterial HTN in children with T1DM-frequent and not easy to diagnose

Out-of-office blood pressure and target organ damage in children and adolescents: a systematic review and meta-analysis

An update on hypertension in children with type 1 diabetes

Twenty-four hour ambulatory blood pressure monitoring in adolescents with type 1 diabetes: getting started

Impaired systolic blood dipping and nocturnal hypertension: an independent predictor of carotid intima-media thickness in type 1 diabetic patients

Poor glycemic control is associated with abnormal changes in 24-hour ambulatory blood pressure in children and adolescents with type 1 diabetes mellitus

Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes

Ambulatory blood pressure and carotid intima media thickness in children with type 1 diabetes

Ambulatory blood pressure monitoring and serum nitric oxide concentration in type 1 diabetic children

Can ambulatory blood pressure monitoring detect early diastolic dysfunction in children with type 1 diabetes mellitus: correlations with B-type natriuretic peptide and tissue Doppler findings

Implications of nocturnal hypertension in children and adolescents with type 1 diabetes

Elevated E-selectin and diastolic blood pressure in diabetic children

Study of ambulatory blood pressure in diabetic children: prediction of early renal insult

Assessment of arterial stiffness from ambulatory blood pressure monitoring in children with diabetes mellitus type-1 (DMT1)

Prehypertension in adolescents with cardiovascular risk: a comparison between type 1 diabetic patients and overweight subjects

Ambulatory blood pressure monitoring in children and adolescents with type-1 diabetes mellitus and its relation to diabetic control and microalbuminuria

Evaluation of neutrophil gelatinase-associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents

Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients

Non-invasive detection of microvascular changes in a paediatric and adolescent population with type 1 diabetes: a pilot cross-sectional study

Blood pressure regulation determined by ambulatory blood pressure profiles in children and adolescents with type 1 diabetes mellitus: impact on diabetic complications

HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes

Blood pressure during sleep is associated with arterial stiffness and urine microalbumin to creatinine ratio in youth with type 1 diabetes

Masked hypertension and its associations with glycemic variability metrics in children and adolescents with type 1 diabetes

Factors influencing blood pressure and microalbuminuria in children with type 1 diabetes mellitus: salt or sugar?

Maternal but not paternal association of ambulatory blood pressure with albumin excretion in young offspring with type 1 diabetes

Association of angiotensin-converting enzyme DD genotype with 24-h blood pressure abnormalities in normoalbuminuric children and adolescents with type 1 diabetes

Blood pressure disturbances and endothelial dysfunction markers in children and adolescents with type 1 diabetes

Alterations of blood pressure in type 1 diabetic children and adolescents

Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetes

Arterial stiffness, BMI, dipping status and ACE D/I polymorphism in type 1 diabetic children

QT interval prolongation in association with impaired circadian variation of blood pressure and heart rate in adolescents with type 1 diabetes

Early signs of left ventricular dysfunction in adolescents with type 1 diabetes mellitus: the importance of impaired circadian modulation of blood pressure and heart rate

Autonomic blood pressure control in children and adolescents with type 1 diabetes mellitus

Microalbuminuria in relation to metabolic control and blood pressure in adolescents with type 1 diabetes

Early changes in 24-hour ambulatory blood pressure are associated with high normal albumin excretion rate in children with type 1 diabetes mellitus

Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes

Hyperfiltration, urinary albumin excretion, and ambulatory blood pressure in adolescents with type 1 diabetes mellitus

Renal functional changes in relation to hemodynamic parameters during exercise test in normoalbuminuric insulin-dependent children

Exercise-induced albuminuria circadian variations in blood pressure in type 1 diabetes

Early kidney damage in diabetic adolescents with increased blood pressure and glomerular hyperfiltration

Clinical applications for out-of-office blood pressure monitoring

Who's using PDAs? Estimates of PDA use by health care providers: a systematic review of surveys

Momentary assessment of social context and glucose monitoring adherence in adolescents with type 1 diabetes

Cognitive function is disrupted by both hypo-and hyperglycemia in school-aged children with type 1 diabetes: a field study

Detection of hypoglycemia by children with type 1 diabetes 6 to 11 years of age and their parents: a field study

Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology

Barriers to glucose testing and attitudes toward mobile app and device use in a large cohort of T1D pediatric patients: implications for diabetes management

A mobile app identifies momentary psychosocial and contextual factors related to mealtime self-management in adolescents with type 1 diabetes

Improving diabetes care for young people with type 1 diabetes through visual learning on mobile phones: mixed-methods study

Prospective assessment of hypoglycemia symptoms in children and adults with type 1 diabetes

Digital diabetes management application improves glycemic outcomes in people with type 1 and type 2 diabetes

An intervention by a patient-designed do-it-yourself mobile device app reduces HbA1c in children and adolescents with type 1 diabetes: a randomized double-crossover study

Use of a novel smartphone-based diabetes management system improved feelings of confidence and safety and reduced hypoglycemia fear among parents/caregivers of children/adolescents with type 1 diabetes

Pilot study of a novel application for data visualization in type 1 diabetes

Use of a mobile app to facilitate blood glucose monitoring in adolescents with type 1 diabetes: single-subject nonrandomized clinical trial

A mobile app for synchronizing glucometer data: impact on adherence and glycemic control among youths with type 1 diabetes in routine care

Mobile momentary assessment and biobehavioral feedback for adolescents with type 1 diabetes: feasibility and engagement patterns

Using a cell phone-based glucose monitoring system for adolescent diabetes management

Contracting and monitoring relationships for adolescents with type 1 diabetes: a pilot study

Smartphone app as motivational intervention to improve glycemic control in adolescents with type 1 diabetes

Parent-child interaction using a mobile and wireless system for blood glucose monitoring

Testing a smartphone app (young with diabetes) to improve self-management of diabetes over 12 months: randomized controlled trial

Design of an mHealth app for the self-management of adolescent type 1 diabetes: a pilot study

Developing a patient-centered mHealth app: a tool for adolescents with type 1 diabetes and their parents

Telemedical support to improve glycemic control in adolescents with type 1 diabetes mellitus

Feasibility of the SMART project: a text message program for adolescents with type 1 diabetes

Use of ecological momentary assessment to measure self-monitoring of blood glucose adherence in youth with type 1 diabetes

Outpatient assessment of determinants of glucose excursions in adolescents with type 1 diabetes: proof of concept

Using mobile phones to measure adolescent diabetes adherence

A pilot test of a tailored mobile and web-based diabetes messaging system for adolescents

Computerized Automated Reminder Diabetes System (CARDS): e-mail and SMS cell phone text messaging reminders to support diabetes management

Engagement with a text-messaging intervention improves adherence in adolescents with type 1 diabetes: brief report

Participants' experience and engagement in Check it!: a positive psychology intervention for adolescents with type 1 diabetes

Effect of mobile phone short text messages on glycaemic control in children with type 1 diabetes

Randomized trial of a positive psychology intervention for adolescents with type 1 diabetes

NICH at its best for diabetes at its worst: texting teens and their caregivers for better outcomes

Improving adherence in social situations for adolescents with type 1 diabetes mellitus (T1DM): a pilot study

School-centered telemedicine for children with type 1 diabetes mellitus

Telehealth behavior therapy for the management of type 1 diabetes in adolescents

A randomized controlled trial of telephone calls to young patients with poorly controlled type 1 diabetes

Characterization of youth goal setting in the self-management of type 1 diabetes and associations with HbA1c: the Flexible Lifestyle Empowering Change trial

Improving the care of youth with type 1 diabetes with a novel medical-legal community intervention: the Diabetes Community Care Ambassador Program

Efficacy of automatic bolus calculator with automatic speech recognition in patients with type 1 diabetes: a randomized cross-over trial

Impact of long-term use of eHealth systems in adolescents with type 1 diabetes treated with sensor-augmented pump therapy

Management of adolescents with very poorly controlled type 1 diabetes by nurses: a parallel group randomized controlled trial

Adolescents' participation in their healthcare: a sociomaterial investigation of a diabetes app

Using Instagram as a modified application of photovoice for storytelling and sharing in adolescents with type 1 diabetes

The impact of social media on youth mental health: challenges and opportunities

An overview of the role of social network sites in the treatment of adolescent diabetes

Needs, priorities, and recommendations for engaging underrepresented populations in clinical research: a community perspective

A qualitative study exploring barriers and facilitators of enrolling underrepresented populations in clinical trials and biobanking

Health disparities among youth with type 1 diabetes: a systematic review of the current literature

National Center for Education Statistics

Parent and Family Involvement in education survey of the National Household Education Surveys Program (PFI-NHES

Daily fluctuations in everyday cognition: is it meaningful? J Aging Health

Building on prior knowledge: schema-dependent encoding processes relate to academic performance

A structural analysis of working memory and related cognitive skills in young children

Selectively enhanced development of working memory in musically trained children and adolescents

IQ and neuropsychological predictors of academic achievement

Associations between acute glucose control and peripheral nerve structure and function in type 1 diabetes

Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: a population-based cohort study

Evidence-based behavioral interventions to promote diabetes management in children, adolescents, and families

The authors would like to thank the funding sources that supported work on this viewpoint including the Washington University 

MKR wrote the first draft of this manuscript. All authors (MKR, AM, MRS, JN, and TH) developed the review design, critically reviewed the manuscript, and edited the manuscript.

MRS has family reporting stock in Pfizer. Other authors declared no conflict of interest.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Diabetes, is properly cited. The complete bibliographic information, a link to the original publication on https://diabetes.jmir.org/, as well as this copyright and license information must be included.